Everything tagged "consumer staples" across research, earnings, and macro.
15 articles
Clorox rebuilt profitability in fiscal 2025, but FY2026 guidance was cut sharply as ERP-related inventory drawdown hit sales and margins. The stock looks like a steady staples franchise in repair, with valuation close to fair and upside tied to execution.
Estée Lauder is showing real turnaround momentum, with sales, margins, and cash flow improving as Beauty Reimagined takes hold. Still, the stock already prices in much of the recovery, keeping the call at Hold.
Philip Morris International is evolving beyond cigarettes as smoke-free products reach 41.5% of revenue and margins stay strong. The report keeps PM in Buy territory on durable EPS growth, though valuation and leverage remain key risks.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator